Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-063840)

Filing Details

Accession Number:: 0000950170-25-063840
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-05 20:35:34
Reporting Period:: 2025-05-01

Filing Date:: 2025-05-05
Accepted Time:: 2025-05-05 20:35:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1641281	Bolt Biotherapeutics Inc.	BOLT	Pharmaceutical Preparations (2834)	472804636

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1724190	P. William Quinn	C/O Bolt Biotherapeutics, Inc. 900 Chesapeake Drive Redwood City CA 94063	President, Ceo And Cfo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-12-16	2,500	$0.50	41,272	No	4	P	Direct
Common Stock	Acquisiton	2024-06-06	2,500	$0.64	38,772	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2025-05-01	700,000	$0.00	700,000	$0.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
700,000		2035-04-30	No	4	A	Direct

Footnotes

and therefore exempt under Rule 16b-3(c)
Shares acquired under the issuer's Employee Stock Purchase Plan.
For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025.